• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    2/10/23 1:22:43 PM ET
    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Beverages (Production/Distribution)
    Consumer Staples
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABEV alert in real time by email

     

    During Friday, 48 stocks hit new 52-week lows.

    Key Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Ambev (NYSE:ABEV).
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest company when considering market cap to set a new 52-week low.
    • Soligenix (NASDAQ:SNGX) shares traded down 1193.45% to reach its 52-week low, making it the biggest loser.
    • Vertical Aerospace (NYSE:EVTL) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    The stocks that set new 52-week lows on Friday:

    • Ambev (NYSE:ABEV) stock achieved a new 52-week low on Friday morning, hitting $2.41 and moving down 1.43%.
    • Bank Bradesco (NYSE:BBD) stock hit a yearly low of $2.43. The stock was down 6.98% for the day.
    • Sirius XM Holdings (NASDAQ:SIRI) shares were down 0.42% for the day, having made a 52-week low of $4.72.
    • Hanesbrands (NYSE:HBI) shares set a new 52-week low of $5.60. The stock traded down 0.79%.
    • Sterling Check (NASDAQ:STER) shares set a new yearly low of $11.92 this morning. The stock was down 11.46% on the session.
    • Cronos Group (NASDAQ:CRON) shares made a new 52-week low of $2.26 on Friday. The stock was down 1.72% for the day.
    • Mercer Intl (NASDAQ:MERC) shares fell to $10.55 on Friday, setting a new 52-week low with a shift of down 10.52%.
    • Azul (NYSE:AZUL) stock hit $5.19 on Friday morning, setting a new 52-week low for a change of down 4.59%.
    • Vertical Aerospace (NYSE:EVTL) stock hit a yearly low of $1.94. The stock was 0.0% (flat) for the day.
    • Bridger Aerospace Gr (NASDAQ:BAER) stock hit a new 52-week low of $3.77. The stock was down 2.18% on the session.
    • Guaranty Bancshares (NASDAQ:GNTY) shares hit a yearly low of $31.10. The stock was up 0.09% on the session.
    • Hyzon Motors (NASDAQ:HYZN) shares reached a new 52-week low of $1.25 on Friday morning, moving down 23.94%.
    • Tupperware Brands (NYSE:TUP) shares reached a new 52-week low of $3.72 on Friday morning, moving down 1.28%.
    • Cerberus Cyber Sentinel (NASDAQ:CISO) shares fell to $1.10 on Friday, setting a new 52-week low with a shift of down 6.38%.
    • GreenLight Biosciences (NASDAQ:GRNA) stock hit $0.86 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • AERWINS Technologies (NASDAQ:AWIN) stock hit a yearly low of $2.04. The stock was down 6.11% for the day.
    • Clough Global Equity (AMEX:GLQ) shares hit a yearly low of $6.14. The stock was up 0.33% on the session.
    • Vintage Wine Estates (NASDAQ:VWE) stock achieved a new 52-week low on Friday morning, hitting $1.85 and moving down 5.48%.
    • Heliogen (NYSE:HLGN) stock set a new 52-week low of $0.38 on Friday, moving down 8.33%.
    • NeoVolta (NASDAQ:NEOV) shares set a new yearly low of $1.96 this morning. The stock was down 7.11% on the session.
    • Taysha Gene Therapies (NASDAQ:TSHA) stock broke to a new 52-week low of $1.02 on Friday. Shares of the company traded down 2.38%.
    • P3 Health Partners (NASDAQ:PIII) stock achieved a new 52-week low on Friday morning, hitting $1.05 and moving down 4.0%.
    • 9F (NASDAQ:JFU) stock dropped to a yearly low on Friday of $3.13. Shares traded down 8.92%.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares moved down 2.09% on Friday to hit a new 52-week low of $0.80, drifting down 2.09%.
    • MGO Global (NASDAQ:MGOL) shares set a new 52-week low of $1.79. The stock traded down 9.05%.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock broke to a new 52-week low of $1.86 on Friday. Shares of the company traded down 0.1%.
    • CN Energy Group (NASDAQ:CNEY) shares set a new yearly low of $0.41 this morning. The stock was down 6.33% on the session.
    • Can Fite Biofarma (AMEX:CANF) shares set a new yearly low of $3.35 this morning. The stock was down 4.23% on the session.
    • WiSA Technologies (NASDAQ:WISA) stock achieved a new 52-week low on Friday morning, hitting $5.99 and moving down 4.31%.
    • Tenax Therapeutics (NASDAQ:TENX) shares fell to $1.03 on Friday, setting a new 52-week low with a shift of down 2.73%.
    • Panbela Therapeutics (NASDAQ:PBLA) shares reached a new 52-week low of $1.23 on Friday morning, moving down 7.95%.
    • OceanPal (NASDAQ:OP) stock hit a new 52-week low of $0.62. The stock was down 10.98% on the session.
    • OpGen (NASDAQ:OPGN) stock hit a new 52-week low of $1.45. The stock was down 4.97% on the session.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $0.18 on Friday morning, moving down 1.76%.
    • Reshape Lifesciences (NASDAQ:RSLS) shares hit a yearly low of $5.10. The stock was down 5.06% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ABEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEV
    $ALLR
    $ASTI
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Bridger Aerospace Group Holdings Inc.
    $BAER
    3/31/2026$3.35Buy
    Stifel
    Tenax Therapeutics Inc.
    $TENX
    3/17/2026$35.00Overweight
    Cantor Fitzgerald
    Vertical Aerospace Ltd.
    $EVTL
    2/23/2026Mkt Perform → Underperform
    Raymond James
    SiriusXM Holdings Inc.
    $SIRI
    2/10/2026$24.00Underweight → Neutral
    Analyst
    SiriusXM Holdings Inc.
    $SIRI
    2/6/2026Buy → Neutral
    Seaport Research Partners
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    SiriusXM Holdings Inc.
    $SIRI
    1/27/2026$21.00Neutral
    MoffettNathanson
    Mercer International Inc.
    $MERC
    1/21/2026$2.25Hold → Sell
    TD Cowen
    More analyst ratings

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SiriusXM to Report First Quarter 2026 Operating and Financial Results

    NEW YORK, March 31, 2026 /PRNewswire/ -- SiriusXM (NASDAQ:SIRI) will release its first quarter 2026 operating and financial results on Thursday, April 30, 2026. The company will host an investor conference call that same day at 8:00 a.m. ET. A live webcast of the call will be available on the SiriusXM Investor Relations website at https://investor.siriusxm.com. Participants wishing to join by telephone should dial 1.877.407.4019 (toll-free) or 1.201.689.8337 (local) 10 minutes prior to the start of the call and request connection to the SiriusXM conference call.About Sirius XM H

    3/31/26 4:30:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

    PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions, today reported its financial results for the fourth quarter and full year ended December 31, 2025, and provided a corporate update highlighting recent progress across its CAD-1005 program for HIT and broader 12-LOX inhibitor platform. The update reflects continued progress for CAD-1005, Cadrenal's first-in-class 12-LOX inhibitor for suspected heparin-induced thrombocytopenia (HIT), including completion of its End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administra

    3/31/26 8:45:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress

         Strengthened financial position through disciplined cost management, with a year-end 2025 cash position of $14.7 million and runway into mid-2028Received FDA Fast Track designation for stenoparib, enabling accelerated development in advanced ovarian cancerDurable clinical benefit observed in ongoing stenoparib ovarian cancer study, including patients treated for nearly 30 months, with new Phase 2 protocol implementedExpansion of stenoparib development beyond ovarian cancer with the launch of a VA-funded Phase 2 combination study in recurrent small cell lung cancer TARPON SPRINGS, Fla., March 31, 2026 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2

    3/31/26 8:00:00 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Kellogg Peter R bought $236,600 worth of shares (70,000 units at $3.38) (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    3/10/26 1:18:16 PM ET
    $MERC
    Paper
    Basic Materials

    Director Laberge Alice bought $1,900 worth of shares (1,000 units at $1.90) (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    2/27/26 2:42:29 PM ET
    $MERC
    Paper
    Basic Materials

    Amendment: Trustee Versaci Vincent W bought $15,301 worth of Common Shares of Beneficial Interest (1,882 units at $8.13), increasing direct ownership by 193% to 2,292 units (SEC Form 4)

    4/A - Clough Global Equity Fund (0001316463) (Issuer)

    1/16/26 4:32:48 PM ET
    $GLQ
    Finance/Investors Services
    Finance

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Bridger Aerospace Group with a new price target

    Stifel initiated coverage of Bridger Aerospace Group with a rating of Buy and set a new price target of $3.35

    3/31/26 8:09:54 AM ET
    $BAER
    Aerospace
    Industrials

    Cantor Fitzgerald initiated coverage on Tenax Therapeutics with a new price target

    Cantor Fitzgerald initiated coverage of Tenax Therapeutics with a rating of Overweight and set a new price target of $35.00

    3/17/26 8:15:05 AM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vertical Aerospace Group downgraded by Raymond James

    Raymond James downgraded Vertical Aerospace Group from Mkt Perform to Underperform

    2/23/26 8:34:02 AM ET
    $EVTL
    Aerospace
    Industrials

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    SEC Filings

    View All

    Allarity Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Allarity Therapeutics, Inc. (0001860657) (Filer)

    4/1/26 8:54:39 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cadrenal Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

    8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer)

    4/1/26 7:40:36 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Cadrenal Therapeutics Inc.

    424B5 - Cadrenal Therapeutics, Inc. (0001937993) (Filer)

    4/1/26 7:30:38 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Malik Parente Guilherme

    4 - AMBEV S.A. (0001565025) (Issuer)

    3/26/26 8:52:00 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4 filed by Maffei Gregory B

    4 - SIRIUS XM HOLDINGS INC. (0000908937) (Issuer)

    3/24/26 4:03:25 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    SEC Form 4 filed by Ibrahim Amany

    4 - NeoVolta Inc. (0001748137) (Issuer)

    3/23/26 9:24:59 PM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Bridger Aerospace Names Justin Mogford as General Counsel, Further Strengthening Management Team

    BELGRADE, Mont., March 26, 2026 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. ("Bridger" or the "Company") (NASDAQ:BAER), one of the nation's leading aerial firefighting companies, today announced the appointment of Justin Mogford as General Counsel and Corporate Secretary, effective in April. Mr. Mogford will replace James Muchmore, who is stepping down. Mogford will lead the Company's legal, compliance, and governance functions as Bridger scales its operations and strengthens its leadership. Mogford is a seasoned public company corporate attorney, having spent more than a decade at Bristow Group Inc. (NASDAQ:VTOL), a provider of helicopter offshore energy transportation and s

    3/26/26 7:30:00 AM ET
    $BAER
    $VTOL
    Aerospace
    Industrials
    Transportation Services
    Consumer Discretionary

    Bridger Aerospace Names New Chief Operating Officer to Support Growth & Strengthen Executive Leadership Team

    BELGRADE, Mont., March 04, 2026 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. ("Bridger" or "Bridger Aerospace"), (NASDAQ:BAER, BAERW)), one of the nation's largest aerial firefighting companies, today announced the appointment of Adolphus "Bill" Andrews as Chief Operating Officer, effective March 2nd. Andrews brings more than three decades of aerospace and aviation leadership experience spanning aircraft development, production, flight operations, maintenance, and sustainment across military and commercial platforms and will oversee all operational functions across Bridger Aerospace's fleet, maintenance, and mission support organizations, with a focus on enhancing readiness,

    3/4/26 8:03:00 AM ET
    $BAER
    Aerospace
    Industrials

    CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT

    Experienced AI and enterprise IT operations leader joins Company to accelerate scalable growth, strengthen security architecture, and advance next-generation cyber software innovation Scottsdale, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Dhaval Damania as Executive Vice President of Cybersecurity & IT. This appointment reinforces its continued commitment to operational excellence, innovation, and scalable growth across its next-generation cybersecurity software portfolio. In this role, Damania will lead CISO Global's

    2/23/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Financials

    Live finance-specific insights

    View All

    SiriusXM to Report First Quarter 2026 Operating and Financial Results

    NEW YORK, March 31, 2026 /PRNewswire/ -- SiriusXM (NASDAQ:SIRI) will release its first quarter 2026 operating and financial results on Thursday, April 30, 2026. The company will host an investor conference call that same day at 8:00 a.m. ET. A live webcast of the call will be available on the SiriusXM Investor Relations website at https://investor.siriusxm.com. Participants wishing to join by telephone should dial 1.877.407.4019 (toll-free) or 1.201.689.8337 (local) 10 minutes prior to the start of the call and request connection to the SiriusXM conference call.About Sirius XM H

    3/31/26 4:30:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

    PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions, today reported its financial results for the fourth quarter and full year ended December 31, 2025, and provided a corporate update highlighting recent progress across its CAD-1005 program for HIT and broader 12-LOX inhibitor platform. The update reflects continued progress for CAD-1005, Cadrenal's first-in-class 12-LOX inhibitor for suspected heparin-induced thrombocytopenia (HIT), including completion of its End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administra

    3/31/26 8:45:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress

         Strengthened financial position through disciplined cost management, with a year-end 2025 cash position of $14.7 million and runway into mid-2028Received FDA Fast Track designation for stenoparib, enabling accelerated development in advanced ovarian cancerDurable clinical benefit observed in ongoing stenoparib ovarian cancer study, including patients treated for nearly 30 months, with new Phase 2 protocol implementedExpansion of stenoparib development beyond ovarian cancer with the launch of a VA-funded Phase 2 combination study in recurrent small cell lung cancer TARPON SPRINGS, Fla., March 31, 2026 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2

    3/31/26 8:00:00 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Azul S.A.

    SC 13G - AZUL SA (0001432364) (Subject)

    12/6/24 4:26:59 PM ET
    $AZUL
    Air Freight/Delivery Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:17:41 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary